CN109078025A - 一种九维鱼肝油乳剂及其制备方法 - Google Patents
一种九维鱼肝油乳剂及其制备方法 Download PDFInfo
- Publication number
- CN109078025A CN109078025A CN201811107276.4A CN201811107276A CN109078025A CN 109078025 A CN109078025 A CN 109078025A CN 201811107276 A CN201811107276 A CN 201811107276A CN 109078025 A CN109078025 A CN 109078025A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- added
- purified water
- stirring
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 28
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 235000012716 cod liver oil Nutrition 0.000 claims abstract description 21
- 239000003026 cod liver oil Substances 0.000 claims abstract description 21
- 238000011049 filling Methods 0.000 claims abstract description 18
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 15
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 15
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 15
- 239000011719 vitamin A Substances 0.000 claims abstract description 15
- 229940045997 vitamin a Drugs 0.000 claims abstract description 15
- 238000005303 weighing Methods 0.000 claims abstract description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 14
- 239000000839 emulsion Substances 0.000 claims abstract description 14
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 14
- 239000011718 vitamin C Substances 0.000 claims abstract description 14
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 13
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 13
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 13
- 210000003022 colostrum Anatomy 0.000 claims abstract description 13
- 235000021277 colostrum Nutrition 0.000 claims abstract description 13
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 13
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 13
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 12
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 12
- 239000011570 nicotinamide Substances 0.000 claims abstract description 12
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004615 ingredient Substances 0.000 claims abstract description 11
- 238000012856 packing Methods 0.000 claims abstract description 11
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 11
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 11
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 11
- 239000011709 vitamin E Substances 0.000 claims abstract description 11
- 229940046009 vitamin E Drugs 0.000 claims abstract description 11
- 229930006000 Sucrose Natural products 0.000 claims abstract description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 10
- 239000005720 sucrose Substances 0.000 claims abstract description 10
- 239000003381 stabilizer Substances 0.000 claims abstract description 9
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 8
- 239000000686 essence Substances 0.000 claims abstract description 8
- 239000003755 preservative agent Substances 0.000 claims abstract description 7
- 230000002335 preservative effect Effects 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 6
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 6
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 6
- 239000011720 vitamin B Substances 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims description 28
- 239000008213 purified water Substances 0.000 claims description 25
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 17
- 229910001220 stainless steel Inorganic materials 0.000 claims description 15
- 239000010935 stainless steel Substances 0.000 claims description 15
- 239000005711 Benzoic acid Substances 0.000 claims description 9
- 235000010233 benzoic acid Nutrition 0.000 claims description 9
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- 235000015165 citric acid Nutrition 0.000 claims description 7
- 230000001804 emulsifying effect Effects 0.000 claims description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 7
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 7
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002356 single layer Substances 0.000 claims description 5
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical class [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 5
- 235000010234 sodium benzoate Nutrition 0.000 claims description 5
- 241000251468 Actinopterygii Species 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims 2
- 230000001590 oxidative effect Effects 0.000 claims 2
- LLJZKKVYXXDWTB-UHFFFAOYSA-N acetic acid;sodium Chemical compound [Na].[Na].CC(O)=O LLJZKKVYXXDWTB-UHFFFAOYSA-N 0.000 claims 1
- 125000003916 ethylene diamine group Chemical group 0.000 claims 1
- 210000002249 digestive system Anatomy 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 235000006694 eating habits Nutrition 0.000 abstract description 3
- 229930003270 Vitamin B Natural products 0.000 abstract description 2
- 235000019156 vitamin B Nutrition 0.000 abstract description 2
- 239000003086 colorant Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 description 21
- 229940088594 vitamin Drugs 0.000 description 18
- 229930003231 vitamin Natural products 0.000 description 18
- 235000013343 vitamin Nutrition 0.000 description 18
- 150000003722 vitamin derivatives Chemical class 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 17
- 238000007792 addition Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 102000040350 B family Human genes 0.000 description 7
- 108091072128 B family Proteins 0.000 description 7
- 239000005022 packaging material Substances 0.000 description 7
- 238000007789 sealing Methods 0.000 description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 230000005674 electromagnetic induction Effects 0.000 description 5
- 239000011888 foil Substances 0.000 description 5
- 238000012946 outsourcing Methods 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 4
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 4
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 238000011022 operating instruction Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- QSHVAZMOLNGWSY-UHFFFAOYSA-N 3-butyl-4-methoxyphenol Chemical group CCCCC1=CC(O)=CC=C1OC QSHVAZMOLNGWSY-UHFFFAOYSA-N 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000005232 Glossitis Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003749 cleanliness Effects 0.000 description 2
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 2
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001107 psychogenic effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种九维鱼肝油乳剂及其制备方法,九维鱼肝油乳剂包括原料和辅料,所述原料组分及质量份为鱼肝油20‑30、维生素A 2.6‑3.6、维生素D37.9‑8.9、维生素B12‑3、维生素B21.3‑2.3、维生素B60.5‑1.5、维生素C 80‑90、维生素E0.5‑1.5、烟酰胺0‑0.9、泛酸钙0.5‑1.5;所述辅料包括蔗糖、乳化剂、抗氧化剂、防腐剂、稳定剂、香精,所述辅料与原料的质量比为1:0.033‑0.043;所述制备方法包括称量、配料、灌装、外包装,所述配料包括制备水相、制备初乳、制备复乳、调色等步骤;本发明制备的九维鱼肝油乳剂,不仅能促进人体对钙的吸收,还可以补充由于紧张的生活、工作压力中不当的饮食习惯而造成的维生素B的缺乏,可以帮助维持心脏、神经系统功能,维持消化系统及皮肤的健康,参与能量代谢,能增强体力、滋补强身。
Description
技术领域
本发明涉及一种鱼肝油制剂的制备,具体为一种九维鱼肝油乳剂及其制备方法。
背景技术
鱼肝油本品系自鲛类动物等无毒海鱼肝脏中提出的一种脂肪油,在0℃左右脱去部分固体脂肪后,用精炼食用植物油、浓度较高的鱼肝油或维生素A与维生素D3调节浓度,再加适量的稳定剂制成,每1g中含维生素A应为标示量的90.0%以上,维生素D应为标示量的85.0%。鱼肝油中的维生素A可促进视觉细胞内感光色素的形成,调试眼睛适应外界光线强弱的能力,以降低夜盲症和视力减退的发生,维持正常的视觉反应。维生素D有助于促进人体对钙的吸收,婴幼儿缺乏维生素D会引起佝偻病,成人缺乏维生素D会造成骨骼软化症。
B族维生素是维持人体正常机能与代谢活动不可或缺的水溶性维生素,人体无法自行制造合成,必须额外补充。而紧张的生活、工作压力中,不当的饮食习惯或因某些特定药物的使用,加上B族维生素本身溶于水的属性,均会使人体内的B族维生素快速被消耗。B族维生素可以帮助维持心脏、神经系统功能,维持消化系统及皮肤的健康,参与能量代谢,能增强体力、滋补强身。
维生素B1被称为精神性的维生素,这是因为维生素B1对神经组织和精神状态有良好的影响;维生素B1的缺乏容易引起各种脚气病。
维生素B2进入人体后磷酸化,转变成磷酸核黄素及黄素腺嘌呤二核苷酸,与蛋白质结合成为一种调节氧化-还原过程的脱氢酶。脱氢酶是维持组织细胞呼吸的重要物质。缺乏它,体内的物质的代谢紊乱,出现口角炎、皮炎、舌炎、脂溢性皮炎、结膜炎和角膜炎等。
维生素B6是机体内许多重要酶系统的辅酶,参与氨基酸的脱羧作用、色氨酸的合成、含硫氨基酸的代谢和不饱和脂肪酸的代谢等生理过程,是动物正常发育、细菌和酵母繁殖所必需的营养成分。缺乏维生素B6容易引起:贫血症、脂溢性皮肤炎、舌炎。
维生素B3:又叫烟酸,有助于促进消化系统健康,改善肠胃功能障碍和腹泻;有助于降低血液中胆固醇和甘油三酯水平;医学上还用于改善口腔炎,防止口臭。
维生素B5:又叫泛酸、抗压维生素,因为它有助于肾上腺素(帮助人体应对紧急情况的激素)的产生,从而有效缓解压力和疲劳。泛酸与维生素C一起食用,还有助于保持肌肤活力,加快伤口愈合。
中国专利(CN104000780A)以及中国专利(CN108283649A)公开了一种三维鱼肝油,包括维生素A、维生素D3和维生素C,中国专利(CN107802648A)以及中国专利(CN108175102A)公开了一种含有维生素E的天然鱼肝油,但是没有包含人体必须的B族维生素,由于B族维生素广泛存在于米糠、麸皮、酵母、动物的肝脏、粗粮蔬菜等食物中,但由于食用方法不对,几乎摄取不到,而且B族维生素是一种水溶性的维生素,普通的复合维生素片属于人工合成维生素,因此开发一种含有B族维生素的鱼肝油作为人们日常补充,特征是针对婴幼儿和孕产妇具有重要的意义。
发明内容
本发明的目的在于提供一种补肾健脾中药制剂的制备方法,解决上述背景中提出的问题。
一种九维鱼肝油乳剂及其制备方法,包括原料和辅料,所述原料组分及质量份为鱼肝油3kg、维生素A 0.36kg、维生素D30.89kg、维生素B10.3kg、维生素B20.23kg、维生素B60.15kg、维生素C9kg、维生素E0.15kg、烟酰胺0.09kg、泛酸钙0.15kg。。
优选地,所述原料组分及质量份为鱼肝油30、维生素A 3.6、维生素D38.9、维生素B13、维生素B22.3、维生素B61.5、维生素C90、维生素E1.5、烟酰胺0.9、泛酸钙1.5。
进一步地,所述辅料包括蔗糖、乳化剂、抗氧化剂、防腐剂、稳定剂、香精,所述辅料与原料的质量比为1:0.033-0.043。
进一步地,所述乳化剂为聚山梨酯-80,抗氧化剂为枸橼酸和叔丁基对羟基茴香醚,防腐剂为苯甲酸和苯甲酸纳,稳定剂为乙二胺四乙酸二钠,所述香精为乳化香精、食用香精和香兰素。
一种九维鱼肝油乳剂的制备方法,包括称量、配料、灌装、外包装,所述配料包括以下步骤:
制备水相:在溶糖罐中加入纯化水,沸腾后,边搅拌边加入蔗糖,保温后泵入配料罐中搅拌混合,在所述配料罐中加入纯化水、防腐剂、抗氧化剂、稳定剂,搅拌保温;
制备初乳:称取鱼肝油放至不锈钢桶内加热,然后将维生素A,维生素D3、维生素E加入其中搅拌,再将乳化剂加入继续搅拌制成初乳;
制备复乳:称取维生素C、维生素B1、维生素B2、维生素B6、泛酸钙、烟酰胺放至不锈钢桶内用纯化水充分溶解,加入至配料罐中搅拌,将初乳加入配料罐中,搅拌制成复乳;
调色:在复乳中加入香料,用纯化水加至足量搅拌后泵至单层卧式储罐。
进一步地,所述配料包括以下步骤:
制备水相:在溶糖罐中加入800kg纯化水,开汽煮至沸腾,将300kg蔗糖投入溶糖罐中,在100℃保温30分钟,然后经过滤泵泵至配料罐中搅拌混合,降温至50℃,所述配料罐中装1700kg纯化水,开汽升温至80℃加入1.5kg苯甲酸钠、3.0kg苯甲酸、3kg枸橼酸、0.6kg乙二胺四乙酸二钠,搅拌60分钟后(450r/min),降温至60℃以下并保温;
制备初乳:称取3kg鱼肝油放至50L的不锈钢桶内加热至60℃,然后将0.36kg维生素A,0.89g维生素D3、0.15kg维生素E、0.12g叔丁基对羟基茴香醚加入其中搅拌10分钟,再将10.8kg聚山梨酯-80加入继续搅拌10分钟后,再加30kg 60℃的纯化水中搅拌10分钟制成初乳;
制备复乳:称取9kg维生素C、0.3kg维生素B1、0.23kg维生素B2、0.15kg维生素B6、0.15kg泛酸钙、90g烟酰胺放至50L的不锈钢桶内用20kg纯化水充分溶解,加入至配料罐中搅拌,将初乳加入至配料罐中,混合搅拌90分钟制成复乳;
调色:所述复乳中加入1.5kg香兰素、9kg桔子香精、3kg乳化香精,用纯化水加至足量,搅拌30分钟后泵至单层卧式储罐。
有益效果:
本发明制备的九维鱼肝油乳剂,不仅能促进人体对钙的吸收,还可以补充由于紧张的生活、工作压力中不当的饮食习惯而造成的维生素B的缺乏,可以帮助维持心脏、神经系统功能,维持消化系统及皮肤的健康,参与能量代谢,能增强体力、滋补强身。
本发明通过乳化剂、抗氧化剂、稳定剂等将水溶性维生素和脂溶性维生素溶解于鱼肝油中,产品营养丰富、口感味道佳,满足婴幼儿和孕产妇的营养需求。
附图说明
图1为本发明生产工艺流程图。
具体实施方式
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体图示,进一步阐述本发明。
实施例1
产品名称:九维鱼肝油
一、生产处方:
表1 九维鱼肝油生产处方表
原辅料名称 | 1000ml | 300万ml |
鱼肝油 | 1g | 3 kg |
维生素A | 118500单位 | 0.36kg |
维生素D<sub>3</sub> | 11850单位 | 0.89g |
维生素B<sub>1</sub> | 0.1g | 0.3kg |
维生素B<sub>2</sub> | 0.075g | 0.23kg |
维生素B<sub>6</sub> | 0.05g | 0.15kg |
维生素C | 3g | 9kg |
维生素E | 0.05g | 0.15kg |
烟酰胺 | 0.03g | 0.09kg |
泛酸钙 | 0.05g | 0.15kg |
乙二胺四乙酸二钠(EDTA) | 0.2g | 0.6kg |
聚山梨酯80 | 3.6g | 10.8kg |
叔丁基-4-羟基茴香醚(BHA) | 0.04g | 0.12kg |
蔗糖 | 100g | 300kg |
苯甲酸 | 1g | 3kg |
苯甲酸钠 | 0.5g | 1.5kg |
枸橼酸 | 1g | 3 kg |
香兰素 | 0.5g | 1.5kg |
食用香精 | 3g | 9kg |
乳化香精 | 1ml | 3 kg |
纯化水 | 加至足量 | 加至足量 |
二.生产工艺的操作要求
1、领料
领料员凭批生产指令;执行《领料岗位标准操作程序》(SOP-PM-101-00)到物料部领取相应的原辅料并复核所领原料的包装标签上的品名、数量、规格与批生产指令是否一致,并检查包装有无破损。
将所领物料运送到生产区的脱外包间,执行《物料进出洁净区标准操作程序》(SOP-HM-003-00)并分别脱去物料的外包装。
将内包装用75%的乙醇溶液擦拭或紫外灯照射30分钟或自净30分钟后,对物料表面进行杀菌。并用洁净周转桶装好,填写好物料传递单,运至生产区。
2、称量(按处方投料)
检查本岗位是否有清场合格证、设备是否完好、已清洁等状态标志。
称量备料:按《称量岗位标准操作程序》(SOP-PM-102-00)、《电子台秤标准操作程序》进行操作。根据批生产指令,核对物料标签,对品名、批号、数量、规格等。按批记录称量原辅料经QA复核后,填写物料传递单,移交下工序。
称量完毕后,执行《电子台秤清洁SOP》、《清场标准操作程序》进行清场,清场完毕,填写清场记录,由QA检查合格后发放清场合格证。
3、配料(按处方投料)
检查本岗位是否具有清场合格证,设备与器具是否完好,已清洁等状态标志。
执行《溶糖、炼蜜岗位标准操作程序》(SOP-PM-116-00),《液体配料岗位标准操作程序》(SOP-PM-117-00)。
制备水相:将RT-2.0溶糖罐加装800kg纯化水,开汽煮至沸腾,边搅拌(30r/min)边将300kg蔗糖投入RT-2.0溶糖罐中,在100℃保温30分钟。然后经G-Y不锈钢多层过滤器过滤泵至PZ-3.0配料罐中搅拌混合,降温至50℃。
4.3.3.2将PZ-3.0配料罐装1700kg纯化水,开汽升温至80℃加入、1.5kg苯甲酸钠、3.0kg苯甲酸、3kg枸橼酸、0.6kg乙二胺四乙酸二钠,搅拌60分钟后(450r/min),降温至60℃以下并保温。
制备初乳:称取3kg鱼肝油放至50L的不锈钢桶内加热至60℃,然后将0.36kg维生素A,0.89g维生素D3、0.15kg维生素E、0.12g叔丁基对羟基茴香醚加入其中搅拌10分再将10.8kg聚山梨酯-80加入继续搅拌10分钟后,再加30kg 60℃的纯化水中搅拌10分钟制成初乳。
制备复乳、加香、调色、定容:称取9kg维生素C、0.3kg维生素B1、0.23kg维生素B2、0.15kg维生素B6、0.15kg泛酸钙、90g烟酰胺放至50L的不锈钢桶内用20kg纯化水充分溶解,加入至配料罐中搅拌。将初乳加入至PZ-3.0配料罐中,混合搅拌90分钟,加入1.5kg香兰素、9kg桔子香精、3kg乳化香精,用纯化水加至足量(使总量达约300万ml)搅拌30分钟后泵至CG-3.0单层卧式储罐。填写请检单交QA取样送检(注:在灌装之前,药液在储罐保存时间不得超过12小时)。
4、清场
配料工序完毕后,执行《电子台秤清洁SOP》、《RT-2.0溶糖罐清洁SOP》、《G-Y不锈钢多层过滤器清洁SOP》、《PZ-3.0配料罐清洁SOP》、《清场管理规程》(SMP-PM-010-00)进行清场,清场完毕,填写清场记录,由QA检查合格后发放清场合格证。经QA复核后,填写物料传递单,移交下工序。
5、灌装
检查灌装室是否具有清场合格证、生产许可证,设备与器具是否清洁、完好。
用GCB4D四泵直线式灌装机进行试灌,调整装量合格后进行正式灌装,每隔30分钟测装量一次并记录.试灌药液作回收处理。灌装机操作过程按《GCB4D四泵直线式灌装机标准操作程序》进行。
铝箔封口过程按《DG-1500B型电磁感应铝箔封口机标准操作程序》执行。
操作完毕后,按清洁SOP清场,填写记录交车间主任。
6、外包装
生产准备和操作,执行《外包岗位标准操作程序》(SOP-PM-115-00)。
外包装形式: 500ml/瓶×20瓶/件。
检查外包车间是否有清场合格证、设备是否完好、清洁等状态标志。温度控制在10-30℃,相对湿度控制在35%~75%之间。
按外包装批指令要求领取合格待包装产品及外包装材料,核对待包装产品及包装材料的品名、批号、数量、规格等。
瓶签盖印:先检查本岗位是否有清场合格证等状态标志;按批指令要求领取合格外包装材料,执行《外包装岗位标准操作程序》进行操作,认真核对瓶签章的批号、生产日期、有效期至,经双人复核无误后,方可进行瓶签盖印操作,要求内容必须正确清晰,位置准确。
打码:先检查本岗位是否有清场合格证、设备是否完好、已清洁等状态标志;批指令要求领取合格外包装材料,按《HP-241B热打码机标准操作程序》进行操作,正确安装批号、生产日期、有效期至经双人复核无误后,方可进行打码操作。要求内容必须正确清晰,位置准确;小盒必须打上产品批号、生产日期、有效期至。内容必须正确清晰,位置准确。
贴瓶签、装小盒:按批包装指令要求,用手工包装,每瓶贴上瓶签,小盒盖上工号,要求1瓶装1盒,并放入一张产品说明书。(包装过程中,请现场QA在线取样检验)。
纸箱必须打上产品批号、生产日期、有效期至。内容必须正确清晰,位置准确。
装大箱:按规格要求装箱(500ml/瓶×20瓶/件))不得多装或少装。放入产品合格证,封箱,入库,挂上待检牌。
不合格的包材在QA监督下记数销毁,剩余包材移放至包材暂存间,分类放好,等同一品种同一包装规格生产结束后退回物料部。
按物料平衡计算方法,计算物料平衡,并做好相应记录。
生产完毕后,执行《HP-241B热打码机标准清洁程序》、《清场管理规程》(SMP-PM-010-00)进行清场,由QA检查合格后发放清场合格证。
三、内包、外包设备所在操作间及操作规程
1、主要所用设备及生产场所
表2 主要所用设备及生产场所说明表
设备名称 | 设备型号 | 数量 | 设备编号 | 操作间名称 | 操作间编号 | 洁净度级别 |
电子台秤 | ---- | 1台 | E-115-PR-01 | 配料室 | R19 | D级 |
配料罐 | PZ-3.0 | 1台 | E-214-PR-01 | 配料室 | R19 | D级 |
不锈钢多层过滤器 | G-Y | 1台 | E-196-PR-01 | 配料室 | R19 | D级 |
溶糖罐 | RT-2.0 | 1台 | E-219-PR-01 | 溶糖室 | R15 | D级 |
配料罐 | PZ-0.1 | 1台 | E-215-PR-01 | 配料室 | R19 | D级 |
四泵直线灌装机 | GCB4D | 1台 | E-217-PR-01 | 灌装室 | R20 | D级 |
四泵直线灌装机 | GCB4D | 1台 | E-217-PR-02 | 灌装室 | R20 | D级 |
电磁感应铝箔封口机 | DG-1500B | 1台 | E-149-PR-01 | 灌装室 | R20 | D级 |
电磁感应铝箔封口机 | DG-1500B | 1台 | E-149-PR-02 | 灌装室 | R20 | D级 |
热打码机 | HP-241B | 1台 | E-164-PY-01 | 外包室 | R21 | 一般区 |
捆扎机 | 90-Ⅲ-Ⅱ | 1台 | E-221-PR-01 | 外包室 | R21 | 一般区 |
2、关键设备的操作规程及清洁SOP
表3 关键设备的操作规程及清洁SOP表
设备名称 | 设备型号 | 操作标准程序编号 | 清洁标准程序编号 |
配料罐 | PZ-3.0 | S0P-EM-214-00 | S0P-EC-214-00 |
不锈钢多层过滤器 | G-Y | S0P-EM-196-00 | S0P-EC-196-00 |
溶糖罐 | RT-2.0 | S0P-EM-219-00 | S0P-EC-219-00 |
配料罐 | PZ-0.1 | S0P-EM-215-00 | S0P-EC-215-00 |
四泵直线灌装机 | GCB4D | S0P-EM-217-00 | S0P-EC-217-00 |
电磁感应铝箔封口机 | DG-1500B | S0P-EM-149-00 | S0P-EC-149-00 |
热打码机 | HP-241B | S0P-EM-164-00 | S0P-EC-164-00 |
捆扎机 | 90-Ⅲ-Ⅱ | S0P-EM-221-00 | S0P-EC-221-00 |
四、设备一览表及主要设备生产能力
表4 主要设备及生产能力表
设备名称 | 设备能力 | 型 号 | 产 地 |
配料罐 | 3000L | PZ-3.0 | 温州金榜 |
不锈钢多层过滤器 | 12T/h | G-Y | 温州金榜 |
溶糖罐 | 2000L | RT-2.0 | 温州金榜 |
配料罐 | 100L | PZ-0.1 | 温州金榜 |
四泵直线灌装机 | 1200-3600瓶/h | GCB4D | 长沙中和制药机械有限公司 |
电磁感应铝箔封口机 | 250瓶/分 | DG-1500B | 长沙中和制药机械有限公司 |
热打码机 | 20-70次/分 | HP-241B | 长沙友联 |
捆扎机 | 240条/小时 | 90-Ⅲ-Ⅱ | 长沙友联 |
五、所用原辅料清单(按每批300万ml用量)
表5 所用原辅料清单表
序号 | 原辅料名称 | 规 格 | 用 量(kg) | 代 码 | 用量说明 |
1 | 鱼肝油 | 原料 | 3 kg | YO33-01 | 300万ml用量 |
2 | 维生素A | 原料 | 0.36kg | YO18-01 | 300万ml用量 |
3 | 维生素D3 | 原料 | 0.89g | YO24-01 | 300万ml用量 |
4 | 维生素B<sub>1</sub> | 原料 | 0.3kg | YO19-01 | 300万ml用量 |
5 | 维生素B<sub>2</sub> | 原料 | 0.23kg | YO20-01 | 300万ml用量 |
6 | 维生素B<sub>6</sub> | 原料 | 0.15kg | YO21-01 | 300万ml用量 |
7 | 维生素C | 原料 | 9kg | YO22-01 | 300万ml用量 |
8 | 维生素E | 原料 | 0.15kg | YO25-01 | 300万ml用量 |
9 | 烟酰胺 | 原料 | 90g | YO27-01 | 300万ml用量 |
10 | 泛酸钙 | 原料 | 0.15kg | YO04-01 | 300万ml用量 |
11 | 乙二胺四乙酸二钠(EDTA) | 辅料 | 0.6kg | FO41-01 | 300万ml用量 |
12 | 聚山梨酯80 | 辅料 | 10.8kg | FO21-01 | 300万ml用量 |
13 | 叔丁基-4-羟基茴香醚(BHA) | 辅料 | 0.12kg | FO36-01 | 300万ml用量 |
14 | 蔗糖 | 辅料 | 300kg | F045-01 | 300万ml用量 |
15 | 苯甲酸 | 辅料 | 3kg | F002-01 | 300万ml用量 |
16 | 苯甲酸钠 | 辅料 | 1.5kg | F003-01 | 300万ml用量 |
17 | 枸橼酸 | 辅料 | 3 kg | F019-01 | 300万ml用量 |
18 | 香兰素 | 辅料 | 1.5kg | F039-01 | 300万ml用量 |
19 | 食用香精 | 辅料 | 9kg | F035-01 | 300万ml用量 |
20 | 乳化香精 | 辅料 | 3 kg | F031-01 | 300万ml用量 |
21 | 纯化水 | 辅料 | 加至足量 | F005-01 | 300万ml用量 |
六、所用包装材料清单
1、内包装材料清单
表6 内包装材料清单表
物料名称 | 规格(尺寸ml) | 类型 | 每批用量 | 代码 |
九维鱼肝油C073-01(PET塑瓶) | 300 | 内包材 | 10200个 | BP073-01 |
2、外包装材料清单
表7 外包装材料清单表
七、质量控制点:
表8 九维鱼肝油生产过程中质量控制表
以上显示和描述了本发明的基本原理和主要特征及本发明的优点,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内,本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (6)
1.一种九维鱼肝油乳剂,其特征在于,包括原料和辅料,所述原料组分及质量份为鱼肝油20-30、维生素A 2.6-3.6、维生素D37.9-8.9、维生素B12-3、维生素B21.3-2.3、维生素B60.5-1.5、维生素C 80-90、维生素E0.5-1.5、烟酰胺0-0.9、泛酸钙0.5-1.5。
2.根据权利要求1所述的九维鱼肝油乳剂,其特征在于,所述原料组分及质量份为鱼肝油30、维生素A 3.6、维生素D38.9、维生素B13、维生素B22.3、维生素B61.5、维生素C90、维生素E1.5、烟酰胺0.9、泛酸钙1.5。
3.根据权利要求1所述的九维鱼肝油乳剂,其特征在于,所述辅料包括蔗糖、乳化剂、抗氧化剂、防腐剂、稳定剂、香精,所述辅料与原料的质量比为1:0.033-0.043。
4.根据权利要求3所述的九维鱼肝油乳剂,其特征在于,所述乳化剂为聚山梨酯-80,抗氧化剂为枸橼酸和叔丁基对羟基茴香醚,防腐剂为苯甲酸和苯甲酸纳,稳定剂为乙二胺四乙酸二钠,所述香精为乳化香精、食用香精和香兰素。
5.一种如权利要求1-4任一所述的九维鱼肝油乳剂的制备方法,包括称量、配料、灌装、外包装,其特征在于,所述配料包括以下步骤:
制备水相:在溶糖罐中加入纯化水,沸腾后,边搅拌边加入蔗糖,保温后泵入配料罐中搅拌混合,在所述配料罐中加入纯化水、防腐剂、抗氧化剂、稳定剂,搅拌保温;
制备初乳:称取鱼肝油放至不锈钢桶内加热,然后将维生素A,维生素D3、维生素E加入其中搅拌,再将乳化剂加入继续搅拌制成初乳;
制备复乳:称取维生素C、维生素B1、维生素B2、维生素B6、泛酸钙、烟酰胺放至不锈钢桶内用纯化水充分溶解,加入至配料罐中搅拌,将初乳加入配料罐中,搅拌制成复乳;
调色:在复乳中加入香料,用纯化水加至足量搅拌后泵至单层卧式储罐。
6.根据权利要求5所述的九维鱼肝油乳剂的制备方法,其特征在于,所述配料包括以下步骤:
制备水相:在溶糖罐中加入800kg纯化水,开汽煮至沸腾,将300kg蔗糖投入溶糖罐中,在100℃保温30分钟,然后经过滤泵泵至配料罐中搅拌混合,降温至50℃,所述配料罐中装1700kg纯化水,开汽升温至80℃加入1.5kg苯甲酸钠、3.0kg苯甲酸、3kg枸橼酸、0.6kg乙二胺四乙酸二钠,搅拌60分钟后(450r/min),降温至60℃以下并保温;
制备初乳:称取3kg鱼肝油放至50L的不锈钢桶内加热至60℃,然后将0.36kg维生素A,0.89g维生素D3、0.15kg维生素E、0.12g叔丁基对羟基茴香醚加入其中搅拌10分钟,再将10.8kg聚山梨酯-80加入继续搅拌10分钟后,再加30kg 60℃的纯化水中搅拌10分钟制成初乳;
制备复乳:称取9kg维生素C、0.3kg维生素B1、0.23kg维生素B2、0.15kg维生素B6、0.15kg泛酸钙、90g烟酰胺放至50L的不锈钢桶内用20kg纯化水充分溶解,加入至配料罐中搅拌,将初乳加入至配料罐中,混合搅拌90分钟制成复乳;
调色:所述复乳中加入1.5kg香兰素、9kg桔子香精、3kg乳化香精,用纯化水加至足量,搅拌30分钟后泵至单层卧式储罐。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811107276.4A CN109078025A (zh) | 2018-09-21 | 2018-09-21 | 一种九维鱼肝油乳剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811107276.4A CN109078025A (zh) | 2018-09-21 | 2018-09-21 | 一种九维鱼肝油乳剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109078025A true CN109078025A (zh) | 2018-12-25 |
Family
ID=64842286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811107276.4A Pending CN109078025A (zh) | 2018-09-21 | 2018-09-21 | 一种九维鱼肝油乳剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109078025A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB561179A (en) * | 1941-07-19 | 1944-05-09 | Arnold Mcnitt Talbott | Improvements in the preparation of fat-soluble vitamin compositions |
CN102919547A (zh) * | 2012-11-16 | 2013-02-13 | 石家庄市光华药业有限公司 | 一种中药液体多维及其制备工艺 |
CN104000780A (zh) * | 2014-06-11 | 2014-08-27 | 青岛双鲸药业有限公司 | 一种三维鱼肝油乳剂 |
CN106473149A (zh) * | 2015-08-25 | 2017-03-08 | 广州硕维食品技术有限公司 | 一种多维多矿组合物 |
CN108283649A (zh) * | 2017-06-16 | 2018-07-17 | 湖南中和制药有限公司 | 三维鱼肝油乳及其制备工艺 |
-
2018
- 2018-09-21 CN CN201811107276.4A patent/CN109078025A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB561179A (en) * | 1941-07-19 | 1944-05-09 | Arnold Mcnitt Talbott | Improvements in the preparation of fat-soluble vitamin compositions |
CN102919547A (zh) * | 2012-11-16 | 2013-02-13 | 石家庄市光华药业有限公司 | 一种中药液体多维及其制备工艺 |
CN104000780A (zh) * | 2014-06-11 | 2014-08-27 | 青岛双鲸药业有限公司 | 一种三维鱼肝油乳剂 |
CN106473149A (zh) * | 2015-08-25 | 2017-03-08 | 广州硕维食品技术有限公司 | 一种多维多矿组合物 |
CN108283649A (zh) * | 2017-06-16 | 2018-07-17 | 湖南中和制药有限公司 | 三维鱼肝油乳及其制备工艺 |
Non-Patent Citations (2)
Title |
---|
"九维鱼肝油乳剂", Retrieved from the Internet <URL:https://db.yaozh.com/otc?comprehensivesearchcontent=%E4%B9%9D%E7%BB%B4%E9%B1%BC%E8%82%9D%E6%B2%B9&> * |
百度百科: "九维鱼肝油", Retrieved from the Internet <URL:https://baike.baidu.com/item/%E4%B9%9D%E7%BB%B4%E9%B1%BC%E8%82%9D%E6%B2%B9/1358971?fr=aladdin> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103504293B (zh) | 液态营养组合物 | |
CN106135890A (zh) | 一种有助于骨关节健康的营养组合物 | |
CN102106498A (zh) | 一种减肥代餐粉 | |
CN102550677B (zh) | 一种对中老年人具有保健功能的液态乳制品及其生产方法 | |
CN101143010A (zh) | 糖尿病患者专用营养食品及其制备方法 | |
CN111602720A (zh) | 一种中老年配方奶粉 | |
CN110214940A (zh) | 一种成年人全营养特殊医学用途配方营养液及其制备方法 | |
CN107951015A (zh) | 全营养配方粉及其制备方法 | |
CN108185437A (zh) | 一种肿瘤全营养配方粉及其制备方法 | |
CN102696770A (zh) | 核桃植物蛋白饮品及其制备方法 | |
CN105188409A (zh) | 含有RRRα-生育酚的婴儿营养产品 | |
CN107751992A (zh) | 用于糖尿病合并肾病患者的肠内营养组合物及其制备方法 | |
CN101982197B (zh) | 一种南美油藤多肽口服液 | |
CN104256588A (zh) | 一种特殊医学用途配方食品均衡营养液及其制备方法 | |
CN101715915A (zh) | 一种全营养复合食用粉 | |
CN104379172B (zh) | 营养组合物 | |
CN109078025A (zh) | 一种九维鱼肝油乳剂及其制备方法 | |
CN103874425A (zh) | 转化膳食的方法 | |
CN108208798A (zh) | 全营养配方液及其制备方法 | |
CN112369599A (zh) | 一种酪蛋白型特殊医学用途配方乳剂及其制备方法 | |
CN105815770A (zh) | 不具有大剂量的营养补充剂的副作用的多种维生素/矿物质制剂 | |
CN107173654A (zh) | 一种保健饮料及其制备方法 | |
CN110495588A (zh) | 一种抹茶南瓜复合果酱及其制备方法 | |
CN108244625A (zh) | 一种减肥手术后的营养代餐食品 | |
CN100486607C (zh) | 调理贫血保健食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |